Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| CAFFEINE, CODEINE PHOSPHATE, PARACETAMOL | SOLPADEINE SOLUBLE TAB | 500, 30, 8 | 12.45 | Details | |
| DOXORUBICIN HYDROCHLORIDE | ADRIBLASTINA 50MG VIAL & SOLV | 50 | 116.9 | Details | |
| BUDESONIDE,FORMTEROL | BUFOMIX 160/4.5MCG EASYHALER | 160,4.5 | 158.00 | Details | |
| AMOXICILLIN, CLAVULANIC ACID | AUGMENTIN SR TABLET | 1000, 62.5 | 111.4 | Details | |
| BUDESONIDE,FORMOTEROL FUMARATE | BUFOMIX 320/9MCG EASYHALER | 320,9 | 84.2 | Details | |
| ALOGLIPTIN | VIPIDIA 12.5 mg film-coated tablet | 12.5 | 52.9 | Details | |
| AMLODIPINE BESILATE | ZILDAFIT 5 MG TABLET | 5 | 13.95 | Details | |
| ALOGLIPTIN | VIPIDIA 25 mg film-coated tablet | 25 | 105.85 | Details | |
| AZILSARTAN MEDOXOMIL,CHLORTHALIDONE | EDARBYCLOR 40 MG/12.5 MG TABLET | 40,12.5 | 71.45 | Details | |
| OLMESARTAN MEDOXOMIL,HYDROCHLOROTHIAZIDE | CO-OLMEPRESS 40 mg/12.5 mg F.C. Tablet | 40,12.5 | 66.15 | Details | |
| ONDANSETRON | ONDRON 2MG/ML AMPOULE | 2 | 56.1 | Details | |
| AZILSARTAN MEDOXOMIL,CHLORTHALIDONE | EDARBYCLOR 40 MG/25 MG TABLET | 40,25 | 71.45 | Details | |
| LEVOCETIRIZINE DIHYDROCHLORIDE | LAYAL 5 mg film-coated tablet | 5 | 7.95 | Details | |
| ALOGLIPTIN,PIOGLITAZONE | CYERO 25/15 mg Tablet | 25,15 | 137.6 | Details | |
| ATOMOXETINE HYDROCHLORIDE | STRATTERA 10MG CAPSULES | 10 | 224.55 | Details | |
| AZILSARTAN MEDOXOMIL | EDARBI 40 mg tablet | 40 | 65.2 | Details | |
| LIFITEGRAST | XIIDRA 50 MG/ML EYE DROPS | 50 | 361.5 | Details | |
| AZILSARTAN MEDOXOMIL | EDARBI 80 mg tablet | 80 | 97.85 | Details | |
| GLUCOSE | GLUCOSE 10% INF. | 10 | 4.45 | Details | |
| LIDOCAINE HYDROCHLORIDE | XYLOCAIN 10% SPRAY 10MG-DOSE | 10 | 25.75 | Details |
7.14% of users said yes from 112 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.